Brachytherapy error halts treatment at Canadian center

A cancer center in Hamilton, Ontario, has suspended brachytherapy treatment...Read more on AuntMinnie.com
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

This study aimed to compare external radiation (beam radiation) and internal radiation as a single radiation therapy to advanced HCC patients (TNA stage III and IV according to the derived AJCC Stage, 6th edition) stratified by other risk factors, based on the data collected from the Surveillance, Epidemiology and End Results (SEER) national database. In this cohort study, we mainly clarified the following three points: 1. Choices of radiation therapy for advanced HCC patients vary in demographic and clinical factors. Among these, TNM classification is the key factor. 2. Internal radiation provides a better prognosis in bo...
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Research Paper Source Type: research
Conclusions: Our findings demonstrate that a dose of 62.5 Gy to positive LNs using the IMRT with SIB method can achieve excellent clinical outcomes with acceptable toxicity.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Research Paper Source Type: research
Publication date: May 2019Source: European Urology Supplements, Volume 18, Issue 3Author(s): K. Jokubonis, D. Milonas, Z. Venclovas, K. Vaiciunas
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
CONCLUSION: Among women with stage III uterine cancer, combination chemotherapy and external beam radiation is associated with decreased mortality compared with chemotherapy or radiation alone. PMID: 31188310 [PubMed - as supplied by publisher]
Source: Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Obstet Gynecol Source Type: research
CONCLUSIONS: The first results of treatment with the Axxent eBT device are promising, as no recurrences have been observed and toxicity is very low. eBT is a good alternative for treating cervical cancer in centers without access to conventional HDR. PMID: 31183970 [PubMed - as supplied by publisher]
Source: Journal of Applied Clinical Medical Physics - Category: Physics Authors: Tags: J Appl Clin Med Phys Source Type: research
The purpose of this study was to review outcomes of women with Stage II endometrial carcinoma with inner half cervical stromal invasion treated with adjuvant vaginal brachytherapy (VB) alone.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
Publication date: Available online 4 June 2019Source: European UrologyAuthor(s): Sebastian Berg, Alexander Cole, Quoc-Dien Trinh
Source: European Urology - Category: Urology & Nephrology Source Type: research
Abstract A patient-specific applicator guide system (PSAG) for tongue-cancer high-dose-rate (HDR) interstitial brachytherapy (ISBT) was developed by utilizing a 3D printing technique. An effectiveness of the 3D-printed PSAG (3D-PSAG) was evaluated for HDR ISBT. Six patients with tongue cancer were retrospectively selected for this study. For each patient, a total of three virtual clinical target volumes (CTV) requiring the insertion of four catheters (CTV4), six catheters (CTV6), and eight catheters (CTV8) were defined. For each CTV, treatment plans were generated to deliver 45 Gy in nine fractions. The 3D-PSAG wa...
Source: Physics in Medicine and Biology - Category: Physics Authors: Tags: Phys Med Biol Source Type: research
This review was to focus on breast brachytherapy cosmetic assessment methods state of the art and to define the advantages and disadvantages related to.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Tags: Review Article Source Type: research
Cancer Gene Therapy, Published online: 03 June 2019; doi:10.1038/s41417-019-0104-zHITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases
Source: Cancer Gene Therapy - Category: Cancer & Oncology Authors: Source Type: research
More News: Brachytherapy | Canada Health | Cancer | Cancer & Oncology